» Articles » PMID: 33534063

The Enigma of Prodromes in Hereditary Angioedema (HAE)

Overview
Date 2021 Feb 3
PMID 33534063
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

A prodrome is a premonitory set of signs and symptoms indicating the onset of a disease. Prodromes are frequently reported by hereditary angioedema (HAE) patients, antedating attacks by a few hours or even longer. In some studies, high incidence of prodromes was reported by patients, with considerable number being able to predict oncoming attacks. Regrettably, prodromes have never received a consensual definition and have not been properly investigated in a systematic fashion. Therefore, their nature remains elusive and their contribution to the diagnosis and treatment of disorders is uncertain. The term "prodrome," as used in various pathologies, denotes different meanings, timing, and duration, so it may not be equally suitable for all clinical situations. Perception of a prodrome is unique for each individual patient depending on self-experience. As modern drugs delegate the administration decision to the patients, early detection of a developing attack may help mitigate its severity and allow deployment of appropriate therapy. New diagnostic instruments were recently developed that can assist in defining the attributes of prodromes and their association with attacks. We will review the prodrome phenomenon as exhibited in certain clinical situations, with an emphasis on prodromes of HAE.

Citing Articles

Neurologic and Psychiatric Manifestations of Bradykinin-Mediated Angioedema: Old and New Challenges.

Mormile I, Palestra F, Petraroli A, Loffredo S, Rossi F, Spadaro G Int J Mol Sci. 2023; 24(15).

PMID: 37569559 PMC: 10419085. DOI: 10.3390/ijms241512184.


National survey on clinical and genetic characteristics of patients with hereditary angioedema in Latvia.

Kanepa A, Nartisa I, Rots D, Gailite L, Farkas H, Kurjane N Allergy Asthma Clin Immunol. 2023; 19(1):28.

PMID: 37031173 PMC: 10082512. DOI: 10.1186/s13223-023-00783-6.


Prodromes predict attacks of hereditary angioedema: Results of a prospective study.

Leibovich-Nassi I, Golander H, Reshef A Allergy. 2022; 78(2):577-579.

PMID: 36259763 PMC: 10092815. DOI: 10.1111/all.15556.


The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update.

Maurer M, Magerl M, Betschel S, Aberer W, Ansotegui I, Aygoren-Pursun E World Allergy Organ J. 2022; 15(3):100627.

PMID: 35497649 PMC: 9023902. DOI: 10.1016/j.waojou.2022.100627.


Hereditary Angioedema: Diagnostic Algorithm and Current Treatment Concepts.

Jindal A, Bishnoi A, Dogra S Indian Dermatol Online J. 2021; 12(6):796-804.

PMID: 34934714 PMC: 8653746. DOI: 10.4103/idoj.idoj_398_21.

References
1.
Reshef A, Kidon M, Leibovich I . The Story of Angioedema: from Quincke to Bradykinin. Clin Rev Allergy Immunol. 2016; 51(2):121-39. DOI: 10.1007/s12016-016-8553-8. View

2.
Prematta M, Bewtra A, Levy R, Wasserman R, Jacobson K, Machnig T . Per-attack reporting of prodromal symptoms concurrent with C1-inhibitor treatment of hereditary angioedema attacks. Adv Ther. 2012; 29(10):913-22. DOI: 10.1007/s12325-012-0053-5. View

3.
Blau J . Migraine prodromes separated from the aura: complete migraine. Br Med J. 1980; 281(6241):658-60. PMC: 1714112. DOI: 10.1136/bmj.281.6241.658. View

4.
Amery W, WAELKENS J, Vandenbergh V . Migraine warnings. Headache. 1986; 26(2):60-6. DOI: 10.1111/j.1526-4610.1986.hed2602060.x. View

5.
Kelman L . The premonitory symptoms (prodrome): a tertiary care study of 893 migraineurs. Headache. 2004; 44(9):865-72. DOI: 10.1111/j.1526-4610.2004.04168.x. View